267 Appendices A 74. I. van Steenoven: Cerebrospinal fluid biomarkers in dementia with Lewy bodies – towards a biological diagnosis (22-09-2020) 75. N. Beker: Cognition in centenarians – evaluation of cognitive health and underlying factors in centenarians from the 100-plus study (02-10-2020) 76. F. de Leeuw: Nutrition and metabolic profiles in Alzheimer’s disease (30-11-2020) 77. T. Timmers: Tau PET across the Alzheimer’s disease continuum (02-12-2020) 78. E.E. Wolters: Untangling tau pathology using PET (02-12-2020) 79. A.S. Doorduijn: Nutrition, the unrecognized determinant in Alzheimer’s disease (12-012021) 80. A. de Wilde: Visualizing Brain Amyloid-beta Pathology (17-03-2021) 81. C. Groot: Heterogeneity in Alzheimer’s Disease (06-04-2021) 82. D. Bertens: The use of biomarkers in non-demented AD patients for clinical trial design and clinical practice (14-04-2021) 83. J. Reimand: Discordance between amyloid-β PET and CSF biomarkers: Clinical and pathophysiological consequences (12-05-2021) 84. L.E. Colij: The AMYPAD project: Towards the next stage in amyloid PET imaging (01-072021) 85. C.T. Briels: Evaluation and implementation of functional cerebral biomarkers in Alzheimer’s disease (15-05-2021) 86. M.M.J. Linszen: Understanding hallucinations outside the context of psychotic disorders (27-09-2021) 87. N. Tesi: The Genetics of Cognitively Healthy Centenarians (28-09-2021) 88. L.M. Reus: Triangulating Heterogeneity in Dementia (28-09-2021) 89. R. Babapour Mofrad: The use of Biofluid biomarkers in dementia: implementation in clinical practice and breaking new grounds (08-10-2021) 90. E.H. Thijssen: Blood-based biomarkers for Alzheimer’s disease: assay development and clinical validation (15-11-2021) 91. A.C. Baakman: Innovation in cholinergic enhancement for Alzheimer’s Disease (17-112021) 92. I.M.W. Verberk: Blood-based biomarkers for Alzheimer’s disease coming to fruition (0812-2021) 93. J.F. Leijenaar: Streamlining VCI: Heterogeneity and Treatment Response (11-01-2022) 94. B.D.C. Boon: Deciphering neuropathological heterogeneity in Alzheimer’s Disease: Beyond plaques and tangles (14-01-2022) 95. E.H. Singleton: The behavioral variant of Alzheimer’s disease: A clinical, neuroimaging and neuropathological perspective (02-06-2022) 96. M. van de Beek: The many faces of dementia with Lewy bodies: impact on clinical manifestation, disease burden and disease progression (09-09-2022) 97. W. Pelkmans: Imaging neurodegeneration across the Alzheimer’s disease continuum (03-10-2022)
RkJQdWJsaXNoZXIy MjY0ODMw